BTG International Limited (2008) Treatment of neurodegenerative conditions. GB2442161/B.

Full text not available from this repository.

Abstract

The use of a defined structure lipid glyceride comprising a glycerol moiety esterifed with one or more fatty acid moieties, characterised in that the lipid has a fatty acid moiety at the sn-2 position selected from the group consisting of q -linolenic acid and dihomo- q -linolenic acid for the manufacture of a medicament for the treatment of a neurodegenerative disease is provided characterised in that it is a lipid of formula II <PC>'''wherein <DL TSIZE=10> <DT>R<1> and R<3><DD>are the same and are selected from H, -C(O)(CH2)nCH3 wherein n is selected from 4 to 16, and <DT>R<2><DD>is selected from q -linolenoyl and dihomo- q -linolenoyl-residues. </DL> characterised in that the medicament is for daily dosing at between 1 and 20 grams of the lipid glyceride.

Item Type:	Patent
Additional Information:	Also published as GB2442161 (B) http://worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2442161B&KC=B&FT=D&ND=4&date=20080521&DB=worldwide.espacenet.com&locale=en_EP
Uncontrolled Keywords:	triglycerides, neurodegenerative diseases, multiple sclerosis
Subjects:	T Technology > T Technology (General) > T201 Patents. Trademarks
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Related URLs:	Organisation
Last Modified:	09 Oct 2021 04:46
URI:	http://gala.gre.ac.uk/id/eprint/4322

Actions (login required)

View Item